{"id":1843,"date":"2016-05-12T10:42:17","date_gmt":"2016-05-12T10:42:17","guid":{"rendered":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?p=1843"},"modified":"2016-05-12T11:14:13","modified_gmt":"2016-05-12T11:14:13","slug":"new-clinical-trial-opens","status":"publish","type":"post","link":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/","title":{"rendered":"New Clinical Trial Opens"},"content":{"rendered":"<div class=\"fcbkbttn_buttons_block\" id=\"fcbkbttn_left\"><div class=\"fcbkbttn_button\">\n\t\t\t\t\t<a href=\"https:\/\/www.facebook.com\/\" target=\"_blank\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-content\/plugins\/facebook-button-plugin\/images\/standard-facebook-ico.png\" alt=\"Fb-Button\" \/>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div><div class=\"fcbkbttn_like \"><fb:like href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/\" action=\"like\" colorscheme=\"light\" layout=\"standard\"  width=\"225px\" size=\"small\"><\/fb:like><\/div><\/div><p><a href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/gaps\/\" rel=\"attachment wp-att-1882\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"178\" class=\"size-medium wp-image-1882 alignleft\" src=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/GAPS-300x178.jpg\" alt=\"GAPS\" \/><\/a>The Imperial College sponsored GAPs trial has recently opened to recruitment at Imperial College Healthcare Trust. The multicentre GAPS trial is examining the benefit of graduated compression stockings as an adjunct to low-dose low molecular weight heparin in the prevention of venous thromboembolism in elective surgical inpatients identified as moderate or high risk for venous thromboembolism. The importance of preventing patients from developing VTE is widely recognized.<\/p>\n<p>The aim of this study is to look at whether patients who wear elastic stockings as well as taking anticoagulant medication have a lower chance of developing VTE than patients who take anticoagulant medications only. Participants are randomly allocated to one of two groups:<br \/>\n1) Graduated compression to wear during their hospital stay, as well as taking low molecular weight heparin OR<br \/>\n2) low molecular weight heparin only<\/p>\n<figure id=\"attachment_1875\" aria-describedby=\"caption-attachment-1875\" style=\"width: 300px\" class=\"wp-caption alignright\"><a href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/vernisha-pic\/\" rel=\"attachment wp-att-1875\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"208\" class=\"wp-image-1875 size-medium\" src=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/Vernisha-pic-300x208.jpg\" alt=\"Vernisha pic\" \/><\/a><figcaption id=\"caption-attachment-1875\" class=\"wp-caption-text\">Imperial Research Nurse Vernisha Ali<\/figcaption><\/figure>\n<p>The trial team are all based in the Vascular department and consist of the Chief Investigator, Professor Alun Davies; Co-Investigator, Joe Shalhoub; Trial managers Francine Heatley and Rebecca Lawton and the Imperial research nurse, Vernisha Ali.<\/p>\n<p>If you would like more information regarding the study please contact Vernisha at <a href=\"mailto:vernisha.ali@imperial.nhs.uk\">vernisha.ali@imperial.nhs.uk<\/a> \/ 0203 311 7304 or email the Trial team at <a href=\"mailto:gapstrial@imperial.ac.uk\">gapstrial@imperial.ac.uk<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Imperial College sponsored GAPs trial has recently opened to recruitment at Imperial College Healthcare Trust. The multicentre GAPS trial is examining the benefit of graduated compression stockings as an adjunct to low-dose low molecular weight heparin in the prevention of venous thromboembolism in elective surgical inpatients identified as moderate or high risk for venous [&hellip;]<\/p>\n","protected":false},"author":710,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1843","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Clinical Trial Opens - S&amp;C Staff Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Clinical Trial Opens - S&amp;C Staff Blog\" \/>\n<meta property=\"og:description\" content=\"The Imperial College sponsored GAPs trial has recently opened to recruitment at Imperial College Healthcare Trust. The multicentre GAPS trial is examining the benefit of graduated compression stockings as an adjunct to low-dose low molecular weight heparin in the prevention of venous thromboembolism in elective surgical inpatients identified as moderate or high risk for venous [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/\" \/>\n<meta property=\"og:site_name\" content=\"S&amp;C Staff Blog\" \/>\n<meta property=\"article:published_time\" content=\"2016-05-12T10:42:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-05-12T11:14:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/GAPS-300x178.jpg\" \/>\n<meta name=\"author\" content=\"Kathryn Johnson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ImperialSandC\" \/>\n<meta name=\"twitter:site\" content=\"@ImperialSandC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kathryn Johnson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/\"},\"author\":{\"name\":\"Kathryn Johnson\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/74df9d40eed41ebe1844803a33b0b765\"},\"headline\":\"New Clinical Trial Opens\",\"datePublished\":\"2016-05-12T10:42:17+00:00\",\"dateModified\":\"2016-05-12T11:14:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/\"},\"wordCount\":214,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2016\\\/05\\\/GAPS-300x178.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/\",\"name\":\"New Clinical Trial Opens - S&amp;C Staff Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2016\\\/05\\\/GAPS-300x178.jpg\",\"datePublished\":\"2016-05-12T10:42:17+00:00\",\"dateModified\":\"2016-05-12T11:14:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/74df9d40eed41ebe1844803a33b0b765\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2016\\\/05\\\/GAPS.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/files\\\/2016\\\/05\\\/GAPS.jpg\",\"width\":583,\"height\":345},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/2016\\\/05\\\/12\\\/new-clinical-trial-opens\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Clinical Trial Opens\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#website\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/\",\"name\":\"S&amp;C Staff Blog\",\"description\":\"Surgery and Cancer community news\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/#\\\/schema\\\/person\\\/74df9d40eed41ebe1844803a33b0b765\",\"name\":\"Kathryn Johnson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6be17c403fbe6a9706ce8d4e8299cc64ecde7b59fbf4901e16b304be977c8c5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6be17c403fbe6a9706ce8d4e8299cc64ecde7b59fbf4901e16b304be977c8c5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b6be17c403fbe6a9706ce8d4e8299cc64ecde7b59fbf4901e16b304be977c8c5?s=96&d=mm&r=g\",\"caption\":\"Kathryn Johnson\"},\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/surgeryandcancer\\\/author\\\/kj57\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Clinical Trial Opens - S&amp;C Staff Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/","og_locale":"en_US","og_type":"article","og_title":"New Clinical Trial Opens - S&amp;C Staff Blog","og_description":"The Imperial College sponsored GAPs trial has recently opened to recruitment at Imperial College Healthcare Trust. The multicentre GAPS trial is examining the benefit of graduated compression stockings as an adjunct to low-dose low molecular weight heparin in the prevention of venous thromboembolism in elective surgical inpatients identified as moderate or high risk for venous [&hellip;]","og_url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/","og_site_name":"S&amp;C Staff Blog","article_published_time":"2016-05-12T10:42:17+00:00","article_modified_time":"2016-05-12T11:14:13+00:00","og_image":[{"url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/GAPS-300x178.jpg","type":"","width":"","height":""}],"author":"Kathryn Johnson","twitter_card":"summary_large_image","twitter_creator":"@ImperialSandC","twitter_site":"@ImperialSandC","twitter_misc":{"Written by":"Kathryn Johnson","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#article","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/"},"author":{"name":"Kathryn Johnson","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/74df9d40eed41ebe1844803a33b0b765"},"headline":"New Clinical Trial Opens","datePublished":"2016-05-12T10:42:17+00:00","dateModified":"2016-05-12T11:14:13+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/"},"wordCount":214,"commentCount":0,"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/GAPS-300x178.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/","name":"New Clinical Trial Opens - S&amp;C Staff Blog","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#primaryimage"},"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/GAPS-300x178.jpg","datePublished":"2016-05-12T10:42:17+00:00","dateModified":"2016-05-12T11:14:13+00:00","author":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/74df9d40eed41ebe1844803a33b0b765"},"breadcrumb":{"@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#primaryimage","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/GAPS.jpg","contentUrl":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2016\/05\/GAPS.jpg","width":583,"height":345},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/05\/12\/new-clinical-trial-opens\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/"},{"@type":"ListItem","position":2,"name":"New Clinical Trial Opens"}]},{"@type":"WebSite","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#website","url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/","name":"S&amp;C Staff Blog","description":"Surgery and Cancer community news","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/#\/schema\/person\/74df9d40eed41ebe1844803a33b0b765","name":"Kathryn Johnson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b6be17c403fbe6a9706ce8d4e8299cc64ecde7b59fbf4901e16b304be977c8c5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b6be17c403fbe6a9706ce8d4e8299cc64ecde7b59fbf4901e16b304be977c8c5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b6be17c403fbe6a9706ce8d4e8299cc64ecde7b59fbf4901e16b304be977c8c5?s=96&d=mm&r=g","caption":"Kathryn Johnson"},"url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/author\/kj57\/"}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/1843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/users\/710"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/comments?post=1843"}],"version-history":[{"count":9,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/1843\/revisions"}],"predecessor-version":[{"id":1886,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/1843\/revisions\/1886"}],"wp:attachment":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/media?parent=1843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/categories?post=1843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/tags?post=1843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}